SQZ Biotechnologies Co (CIK: 0001604477) EDGAR, Information, Filings... CompaniesBIO.Com

SQZ Biotechnologies Co

Mailing address
200 ARSENAL YARDS BLVD., STE. 210, WATERTOWN, Delaware, 02472
Phone
617-898-8824
State location
Massachusetts
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Filings
N/A

SQZ Biotechnologies Co (CIK: 0001604477) is an American company incorporated in the state of Massachusetts. Head office is located at 200 ARSENAL YARDS BLVD., STE. 210, WATERTOWN, Massachusetts, 02472. Work in the industry 2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES). SQZ Biotechnologies Co is a public company and trade via Over-The-Counter (OTC).

Owner	Filings	Transaction Date	Type of Owner
Warren Marshelle Smith	0001932203	Jun-01-2022	officer: Chief Medical Officer
Capasso Richard	0001892379	Nov-11-2021	officer: See Remarks
VINK PATRICK V.J.J.	0001557501	Jul-01-2021	director
Coulie Bernard	0001808895	Jul-01-2021	director
AMERICAN INTERNATIONAL GROUP INC	0000005272	Oct-29-2020	10 percent owner
Temasek Holdings (Private) Ltd	0001021944	Oct-29-2020	10 percent owner
Artal Group S.A.	0001053906	Oct-29-2020	10 percent owner
Artal International S.C.A.	0001218180	Oct-29-2020	10 percent owner
LANGER ROBERT	0001239757	Oct-29-2020	10 percent owner
BERNSTEIN HOWARD PHD MD	0001262409	Oct-29-2020	officer: Chief Scientific Officer
Westend S.A.	0001283968	Oct-29-2020	10 percent owner
Invus Public Equities Advisors, LLC	0001340096	Oct-29-2020	10 percent owner
Invus Public Equities, L.P.	0001340097	Oct-29-2020	10 percent owner
SCHULMAN AMY W	0001438226	Oct-29-2020	director, 10 percent owner
Minne Pascal	0001460839	Oct-29-2020	10 percent owner
Stichting Administratiekantoor Westend	0001460840	Oct-29-2020	10 percent owner
Knopf Lawrence J	0001517214	Oct-29-2020	officer: General Counsel
Artal International Management S.A.	0001522131	Oct-29-2020	10 percent owner
Srivastava Sapna	0001569226	Oct-29-2020	director
Polaris Partners VII, L.P.	0001611189	Oct-29-2020	10 percent owner
Polaris Entrepreneurs' Fund VII, L.P.	0001615991	Oct-29-2020	10 percent owner
BOLNO PAUL	0001657710	Oct-29-2020	director
Polaris Management Co. VII, L.L.C.	0001678203	Oct-29-2020	10 percent owner
Rosen Oliver	0001714870	Oct-29-2020	officer: Chief Medical Officer
Artal Treasury Ltd	0001766952	Oct-29-2020	10 percent owner
First David	0001767296	Oct-29-2020	officer: Chief People Officer
SCHEGERIN MARC	0001773184	Oct-29-2020	director
Moesslinger Eric	0001829044	Oct-29-2020	director
Zajic Micah	0001829046	Oct-29-2020	officer: Chief Business Officer
Loxam Teri	0001829111	Oct-29-2020	officer: Chief Financial Officer
Garg Pushkal	0001829252	Oct-29-2020	director
Jensen Klavs F.	0001829257	Oct-29-2020	director
Sharei Armon	0001829463	Oct-29-2020	director, officer: President and CEO
Elia Marc	0001830496	Oct-29-2020	director
Arny Schulman, as Trustee The Armon R. Sharei Irrevocable GST Trust of 2016 U/D/T Dated December 29, 2016	0001830552	Oct-29-2020	10 percent owner

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by SQZ Biotechnologies Co

Filings	Format	Description	Filed/Effective	File/Film Number
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001104659-24-021816 (34 Act) Size: 41 KB	Feb-13-2024	005-91838 24629404
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001193125-24-030293 (34 Act) Size: 133 KB	Feb-09-2024	005-91838 24616095
DEFM14A	Document	Definitive proxy statement relating to a merger,acquisition, or disposition Acc-no: 0001193125-24-013016 (34 Act) Size: 4847 KB	Jan-23-2024	001-39662 24553017
PREM14A	Document	Preliminary proxy statement relating to a merger, acquisition, or disposition Acc-no: 0001193125-24-007135 (34 Act) Size: 4876 KB	Jan-12-2024	001-39662 24530695
15-12G	Document	Notice of termination of registration of a class of securities under Section 12(g) Acc-no: 0001193125-24-002446 (34 Act) Size: 10 KB	Jan-04-2024	001-39662 24512080
8-K	Document	Current report filing Acc-no: 0001193125-23-302228 (34 Act) Size: 693 KB	Dec-22-2023	001-39662 231510822
EFFECT	Document	Acc-no: 9999999995-23-003512 (33 Act) Size: 1 KB	Dec-01-2023	333-260980 231461176
POS AM	Document	Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001193125-23-286282 (33 Act) Size: 18 KB	Nov-30-2023	333-260980 231455943
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001193125-23-286279 (33 Act) Size: 18 KB	Nov-30-2023	333-249774 231455929
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000950170-23-061187 (34 Act) Size: 6012 KB	Nov-08-2023	001-39662 231388359
8-K	Document	Current report filing Acc-no: 0000950170-23-051187 (34 Act) Size: 185 KB	Oct-02-2023	001-39662 231300700
8-K	Document	Current report filing Acc-no: 0000950170-23-048274 (34 Act) Size: 172 KB	Sep-15-2023	001-39662 231256814
10-Q	Document	Quarterly report pursuant to sections 13 or 15(d) Acc-no: 0000950170-23-041405 (34 Act) Size: 6277 KB	Aug-10-2023	001-39662 231160088
8-K	Document	Current report filing Acc-no: 0000950170-23-034223 (34 Act) Size: 182 KB	Jul-25-2023	001-39662 231106455
25-NSE	Document	Acc-no: 0000876661-23-000590 (34 Act) Size: 4 KB	Jul-19-2023	001-39662 231095990
8-K	Document	Current report filing Acc-no: 0000950170-23-032265 (34 Act) Size: 208 KB	Jul-07-2023	001-39662 231077133
8-K	Document	Current report filing Acc-no: 0000950170-23-031345 (34 Act) Size: 180 KB	Jul-03-2023	001-39662 231064609
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-23-037390 ( Act) Size: 5 KB	Jun-15-2023
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-23-037388 ( Act) Size: 5 KB	Jun-15-2023
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001209191-23-037386 ( Act) Size: 5 KB	Jun-15-2023

Recent 20 filings. View all SQZ Biotechnologies Co filings

Overall rating 5.0

Aug 22, 2022

Ryan Storey

Huge help thank you for your help .. y'all make it so much easier

Aug 22, 2022

Catherine

Thanks I look forward to using the product to improve my skin tone

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

SQZ Biotechnologies Co overview
SQZ Biotechnologies Co job
SQZ Biotechnologies Co stock
SQZ Biotechnologies Co ownership
SQZ Biotechnologies Co CEO
SQZ Biotechnologies Co documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.